Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues

Circulation Research

Volumn 81, Issue 4, 1997, Pages 567-574

  Wong, Adrianne L ^a   Haroon, Zishan A ^a   Werner, Sabine ^b   Dewhirst, Mark W ^a   Greenberg, Charles S ^a   Peters, Kevin G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Angiogenesis; Endothelium; Receptor tyrosine kinase; Tie2; Wound healing

Indexed keywords

MESSENGER RNA; PROTEIN TYROSINE KINASE; RIBONUCLEASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; EMBRYO; ENZYME ANALYSIS; ENZYME LOCALIZATION; HISTOPATHOLOGY; HORMONAL REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; VASCULAR ENDOTHELIUM; WOUND HEALING;

EID: 0030764063     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.4.567     Document Type: Article

References (47)

1. Engerman RL, Pfaffenbach D, Davis MD. Cell turnover of the capillaries. Lab Invest. 1967;17:738-743.
2. Hobson B, Denekamp J. Endothelial proliferation in tumors and normal tissues: continuous labeling studies. Br J Cancer. 1984;49: 405-413.
3. Reynolds LP, Killilea SD, Redme DA. Angiogenesis in the female reproductive system. FASEB J. 1992;6:886-892.
4. Kirsner RS, Eaglstein WH. The wound healing proeess. Dermatol Clin. 1993;11:629-640.
5. Clark RA. Biology of dermal wound repair, Dermatol Clin. 1993; 11:647-666.
6. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353-364.
7. Mustonen T, Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol. 1995;129:895-898.
8. Dumont DJ, Gradwohl GJ, Fong G-H, Auerbach R, Breitman ML. The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors. Oncogcne. 1992;8:1293-1302.
9. Partanen J, Armstrong E, Makela TP, Korhonen J, Sandberg M, Renkonen R, Knuutila S, Heubner K, Alitalo K. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol. 1992;12: 1698-1707.
10. Iwama A, Hamaguchi I, Hashiyama M, Murrayama Y, Yasunaga K, Suda T. Molecular cloning and characterization of mouse Tie and Tek receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem Biophys Res Commun. 1993;195: 301-309.
11. Maisonpierre PC, Goldfarb M, Yancopoulos GD, Gao G. Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinasc family. Oncogene. 1992;8:1631-1638.
12. Sato TN, Qin Y, Kozak C, Audus K. Tie-1 and Tie-2 Define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system. Proc Natl Acad Sci U S A. 1993;90:9355-9358.
13. Schnurch H, Risau W. Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development. 1993;119:957-968.
14. Ziegler SF, Bird TA, Schneringer JA, Schooley KA, Baum PR. Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta. Oncogene. 1992;8:663-670.
15. Dumont DJ, Yamaguchi TP, Conlon RA, Rossant J, Breitman ML. Tek, a novel tyrosine kinase gene located on mouse chromosome 4 expressed in endothelial cells and their presumptive precursors. Oncogene. 1992;7:1471-1480.
16. Dumont DJ, Gradwohl G, Fong G-H, Puri MC, Gertsenstein M, Auerbach A, Breitman ML. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 1994;8: 1897-1909.
17. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buohholz K, Fujiwara Y, Gridley T, Wolburg H, Risau W, Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 1995;376:70-74.
18. Partanen J, Puri MC, Schwartz L, Fischer K-D, Bernstein A, Rossant J. Cell autonomous functions of the receptor tyrosine kinase TIE in a late phase of angiogenic capillary growth and endothelial cell survival during murine development. Development. 1996;122:3013-3021.
19. Fontijn R, Hop C, Brinkman H-J, Slater R, Westerveld A, Mourik JA, Pannekoek H. Maintenance of vascular endothelial cell-specific properties after immortalization with an amphotrophic replication-deficient retrovirus containing human papilloma virus 16 E6/E7 DNA. Esp Cell Res. 1995;216:199-207.
20. Arbiser JL. Angiogenesis and the skin: a primer. J Am Acad Dermatol. 1996;34:486-497.
21. Peters KG, De Vries C, Williams LT. Expression of a VEGF receptor in embryos and wounds suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci U S A. 1993;90:8915-8919.
22. Bauters C, Asahara T, Zheng LP, Takeshita S, Burning S, Ferrara N, Symes JF, Isner JM. Recovery in disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation. 1995;91:2802-2809.
23. Vikkula M, Boon LM, Carraway KLI, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB, Olsen BR. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell. 1996;87:1181-1190.
24. Schlessinger J, Ullrich A. Growth factor signaling by receptor tyrosine kinases, Neuron. 1992;9:383-391.
25. van der Geer P, Hunter T, Lindberg RA. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol. 1994;10:251-337.
26. Fantl WJ, Peters KG, Williams LT. PDGF and FGF receptors in health and disease, Growth Factors Cytokines Health Dis. 1996;1A: 179-228.
27. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpiuerre PC, Yancopoulous GD. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 1996;87:1161-1169.
28. Suri C, Jones PF, Patan D, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 1996;87:1171-1180.
29. Huang L, Turck CW, Rao P, Peters KG. GRB2 and SH-PTP2: potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase. Oncogene. 1995;11: 2097-2103.
30. Feng F-S, Pawson T. Phosphotyrosine phosphatases with SH2 domains: regulators of signal transduetion. Trends Genet. 1994;10: 54-58.
31. Downward J. The GRB2/SEM-5 adaptor protein. FEBS Lett. 1994; 338:113-117.
32. Neel BG. Structure and function of SH2 domain containing tyrosine phosphatases. Semin Cell Biol. 1993;4:419-432.
33. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med. 1995;33:1757-1763.
34. Kahlon R, Shapero J, Gotlieb AI. Angiogenesis in atherosclerosis. Can J Cardiol. 1992;8:60-64.
35. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931-10934.
36. Williams JK, Heistad DD. Structure and function of vasa vasorum. Trends Cardiovasc Med. 1996;6:53-57.
37. Barger AC, Beeuwkes RI, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. N Engl J Med. 1984;310:175-177.
38. Imperato AM, Riles TS, Mintzer R, Baumann FG. The importance of hemorrhage in the relationship between gross morphologic characteristics and cerebral symptoms in 376 artery plaques. Ann Surg. 1982;197:195-203.
39. Geary RL, Williams JK, Golden D, Brown DG, Benjamin M, Adams MR. Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis. Atheroscler Thromb Vasc Biol. 1996;16:34-43.
40. Schaper W. New paradigms for collateral vessel growth. Basic Res Cardiol. 1993;88:193-198.
41. Kass RW, Kotler MM, Yazdanfar S. Stimulation of coronary collateral growth: current developments in angiogenesis and future clinical applications. Am Heart J. 1992;123:486-496.
42. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kidon H, Karnijo T, Sugimoto T, Kaji K, Utsuyama M, Kerashima C, Ito H. Salvage of infarcted myocardium by angiogenic growth of basic fibrobiast growth factor. Science. 1992;257:1401-1403.
43. Nabel EG, Yang ZY, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries, in vivo Nature. 1993;362:844-846.
44. Baffour R, Herman J, Garb JL, Rhee SW, Kaufinan J, Friedmann P. Enhanced angiogencsis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg. 1992;16:181-191.
45. Lazarous DF, Scheinowitz M, Shou M, Hodge E, Rajanayagam S, Hunsberger S, Robison WG, Stiber JA, Correa R, Epstein SE, Unger EF. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 1995;91:145-153.
46. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner J. Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am J Physiol. 1994;267:H1263-H1271.
47. Asahara T, Bauters C, Zheng EP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Synergistic effect of vascular endothelial growth factor and basic fibrobiast growth factor on angiogenesis in vivo. Circulation. 1995;92(suppl II):II-365-II-371.